Ocular and periocular histiocytoses

Ophthalmic Plastic and Reconstructive Surgery

Volumn 23, Issue 1, 2007, Pages 8-10

  Karcioglu, Zeynel A ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CLASSIFICATION; DISEASE COURSE; EYE DISEASE; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; JUVENILE XANTHOGRANULOMA; LANGERHANS CELL HISTIOCYTOSIS; NECROBIOTIC XANTHOGRANULOMA; NOMENCLATURE; OCULAR HISTIOCYTOSIS; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; XANTHOGRANULOMA; XANTHOMA;

EYE DISEASES; HISTIOCYTOSIS; HUMANS;

EID: 33846412226     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e31802ca53c     Document Type: Review

References (18)

1. Jaffe R. The histiocytosis. Diagn Pediatr Hematol 1999;19:135-55.
2. Favara BE, Feller AC, Paulli M, et al. Contemporary classification of histiocytic disorders: the WHO Committee on Histiocytic/Reticulum Cell Proliferations: Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997;29:157-66.
3. Weiss LM. Histiocytic and dendritic cell proliferations. In: Knowles DM (ed). Neoplastic Hematopathology. 2nd Ed. Philadelphia: Lippincott Williams & Wilkins; 2001:1815-45.
4. Fartasch M, Vigneswaran N, Diepgen TL, et al. Immunohistochemical and ultrastructural study of histiocytosis X and non-X histiocytosis. J Am Acad Dermatol 1990;23:885-92.
5. Jaffe ES. Histiocytic and dendritic cell neoplasms. In: Jaffe ES, Harris NL, Stein H, et al (eds). Pathology and Genetics. Tumors of Hematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2001:273-7.
6. Zelger B. Langerhans cell histiocytosis: a reactive or neoplastic disorder? Med Pediatr Oncol 2001;37:543-4.
7. Schmitz L, Favara BE. Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:221-46.
8. Chan JKC. Lymphoid, myeloid and histiocytic neoplasms involving soft tissues. In: Miettinen M (ed). Diagnostic Soft Tissue Pathology. New York: Churchill Livingstone; 2003:531-69.
9. Bergman R. The pathogenesis and clinical significance of xanthelasma palpebrarum. J Am Acad Dermatol 1994;30:236-42.
10. Gomez JA, Gonzales MJ, Moragas JM, et al. Apolipoprotein E phenotypes, lipoprotein composition, and xanthelasmas. Arch Dermatol 1988;124:1230-4.
11. Ugurlu S, Bartley GB, Gibson LE. Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvement. Am J Ophthalmol 2000;129:651-7.
12. Kraus MD, Haley JC, Ruiz R, et al. 'Juvenile' xanthogranuloma: an immunophenotypic study with a reappraisal of histogenesis. Am J Dermatopathol 2001;23:104-11.
13. Karcioglu ZA, Mullaney PB. Diagnosis and management of XJG. J Pediatr Ophthalmol Strabismus 1997;34:44-51.
14. Karcioglu ZA, Sharara N, Boles T, Nasr A. Orbital xanthogranuloma: clinical and morphologic features in eight patients. Ophthalmol Plast Reconstr Surg 2003;19:372-81.
15. Chetritt J, Paradis V, Dargere D, et al. Chester-Erdheim disease: a neoplastic disorder. Hum Pathol 1999;30:1093-6.
16. Shields JA, Karcioglu ZA, Shields CL, et al. Orbital and eyelid involvement with Erdheim-Chester disease, a report of two cases. Arch Ophthalmol 1991;109:850-4.
17. Karcioglu ZA, Insler MS, Allam B. Ocular involvement in sinus histiocytosis with massive lymphadenopathy. B J Ophthalmol 1988;72:793-5.
18. Mohadjer Y, Holds JB, Wilson MW, et al. The spectrum of orbital Rosai-Dorfman disease. Ophthal Plast Reconstr Surg 2006;22:163-8.